Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.53 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.53 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.53 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15960454 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL18061241 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL19820215 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL19726096 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL13452662 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL15935719 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL2629594 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL16187917 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL13663174 | 0.92 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 | |
| SCHEMBL13541613 | 0.92 | CD69 (0.61) | CD69ALDH1A1THRBMAPK1LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9937264-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9879097-B2 | Method for producing activated sugar chain derivative and activated sugar chain derivative produced therefrom | GLYTECH, INC. (JP) | 2018-01-30 | — | — | US | disclosed |
| US-9802996-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9708413-B2 | Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof | GLYTECH, INC. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9441024-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2016-09-13 | — | — | US | disclosed |
| US-9422357-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2016-08-23 | — | — | US | disclosed |
| US-20160075799-A1 | A METHOD FOR PRODUCING ACTIVATED SUGAR CHAIN DERIVATIVE AND ACTIVATED SUGAR CHAIN DERIVATIVE PRODUCED THEREFROM | GLYTECH INC (JP) | 2016-03-17 | — | — | US | disclosed |
| US-20150306235-A1 | SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME | GLYTECH INC (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | GLYTECH INC (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20140369964-A1 | GLYCOSYLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | GLYTECH, INC. (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140336116-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GLYTECH, INC. (JP) | 2014-11-13 | — | — | US | disclosed |
| US-20140315800-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GLYTECH, INC. (JP) | 2014-10-23 | — | — | US | disclosed |
| US-20140235822-A1 | METHOD FOR PRODUCING PEPTIDE | GLYTECH, INC. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8809258-B2 | Method for producing peptide | GLYTECH, INC. (JP) | 2014-08-19 | — | — | US | disclosed |
| US-7851618-B2 | Aminated complex-type sugar chain derivatives and process for the production thereof | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20070060543-A1 | Aminated complex-type sugar chain derivatives and process for the production thereof | GLYTECH, INC. (JP) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR4, SSTR3 | CD69 1609/4885ALDH1A1 4735/4885THRB 155/4885 |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | CD44, CSGALNACT1, UGGT1 | CD69 605/4885ALDH1A1 594/4885THRB 3132/4885 |
| US-20140336116-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GIPR, SSTR4, SSTR5 | CD69 1621/4885ALDH1A1 4727/4885THRB 154/4885 |
| US-20160075799-A1 | A METHOD FOR PRODUCING ACTIVATED SUGAR CHAIN DERIVATIVE AND ACTIVATED SUGAR CHAIN DERIVATIVE PRODUCED THEREFROM | SI, ASNS, MGAM | CD69 601/4885ALDH1A1 4231/4885THRB 3322/4885 |
| US-20150306235-A1 | SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME | SI, ENGASE, DNPEP | CD69 705/4885ALDH1A1 886/4885THRB 2764/4885 |
| US-20140235822-A1 | METHOD FOR PRODUCING PEPTIDE | PTMS, HM13, ANPEP | CD69 3832/4885ALDH1A1 4396/4885THRB 2949/4885 |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR3, SSTR4 | CD69 1575/4885ALDH1A1 4739/4885THRB 147/4885 |
| US-20140315800-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GIPR, SSTR3, SSTR4 | CD69 1575/4885ALDH1A1 4739/4885THRB 147/4885 |
| US-20070060543-A1 | Aminated complex-type sugar chain derivatives and process for the production thereof | OSTC, C9, FUT4 | CD69 2683/4885ALDH1A1 1323/4885THRB 971/4885 |
| US-20140369964-A1 | GLYCOSYLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | IFNG, IFNAR1, IAPP | CD69 1150/4885ALDH1A1 3871/4885THRB 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.